These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 9191120)
41. Down-regulation of interleukin-2 receptors beta and gamma chains in human T lymphocytes. Morelon E; Hemar A; Dautry-Varsat A Transplant Proc; 1995 Aug; 27(4):2477. PubMed ID: 7652893 [No Abstract] [Full Text] [Related]
42. Interleukin-15: a new cytokine target for the treatment of inflammatory diseases. McInnes IB; Gracie JA Curr Opin Pharmacol; 2004 Aug; 4(4):392-7. PubMed ID: 15251134 [TBL] [Abstract][Full Text] [Related]
43. Interleukin-15 up-regulates interleukin-2 receptor alpha chain but down-regulates its own high-affinity binding sites on human T and B cells. Kumaki S; Armitage R; Ahdieh M; Park L; Cosman D Eur J Immunol; 1996 Jun; 26(6):1235-9. PubMed ID: 8647198 [TBL] [Abstract][Full Text] [Related]
44. Glutamine requirement of proliferating T lymphocytes. Yaqoob P; Calder PC Biochem Soc Trans; 1996 Feb; 24(1):78S. PubMed ID: 8674758 [No Abstract] [Full Text] [Related]
45. Plaque T-cell activity: not so specific? Stemme S Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1099-101. PubMed ID: 11451736 [No Abstract] [Full Text] [Related]
46. Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF-kappa B site. Mariner JM; Lantz V; Waldmann TA; Azimi N J Immunol; 2001 Feb; 166(4):2602-9. PubMed ID: 11160322 [TBL] [Abstract][Full Text] [Related]
47. Interleukins and the immune system 1. O'Garra A Lancet; 1989 Apr; 1(8644):943-7. PubMed ID: 2565429 [No Abstract] [Full Text] [Related]
49. Proliferation of B cells from chronic lymphocytic leukemia is selectively promoted by B cell growth factor. Alvarez-Mon M; de la Hera A; Gaspar ML; Orfao A; Casas J; Jordá J; Durantez A Acta Haematol; 1989; 81(2):91-7. PubMed ID: 2496557 [TBL] [Abstract][Full Text] [Related]
50. Enhanced B-lymphocyte expression of IL-2R alpha associated with T lymphocytosis in BLV-infected persistently lymphocytotic cows. Stone DM; McElwain TF; Davis WC Leukemia; 1994 Jun; 8(6):1057-61. PubMed ID: 7516028 [TBL] [Abstract][Full Text] [Related]
51. [The interleukin 2 receptor. A review of the literature]. Siegl E; Lehmann M Allerg Immunol (Leipz); 1987; 33(1):3-14. PubMed ID: 2954445 [TBL] [Abstract][Full Text] [Related]
52. [Mechanisms for generation and maintenance of memory CD8 T cells]. Kamimura D; Murakami M Nihon Rinsho; 2005 Apr; 63 Suppl 4():369-74. PubMed ID: 15861683 [No Abstract] [Full Text] [Related]
53. [Cytokines and receptors--their functions, structure and cloning of code genes. Interleukin-2 and receptor]. Tagaya Y; Yodoi J Nihon Rinsho; 1988 May; 46(5):1002-7. PubMed ID: 3137376 [No Abstract] [Full Text] [Related]
54. Differential regulation of human T lymphoblast functions by IL-2 and IL-15. Bulfone-Paus S; Dürkop H; Paus R; Krause H; Pohl T; Onu A Cytokine; 1997 Jul; 9(7):507-13. PubMed ID: 9237813 [TBL] [Abstract][Full Text] [Related]
55. Interleukin-2 receptor signal transduction: translocation of active serine-threonine kinase Raf-1 from IL-2 receptor into cytosol depends on IL-2-induced tyrosine kinase activation. Maslinski W; Remillard B; Tsudo M; Strom TB Transplant Proc; 1993 Feb; 25(1 Pt 1):109-10. PubMed ID: 8438242 [No Abstract] [Full Text] [Related]
56. Stimulator cells produce multiple nonantigen signals that determine T cell activation. Hwang LA; Boyle W Transplant Proc; 1989 Oct; 21(5):3755-6. PubMed ID: 2530674 [No Abstract] [Full Text] [Related]
57. The Sushi domain of soluble IL-15 receptor alpha is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivo. Wei Xq ; Orchardson M; Gracie JA; Leung BP; Gao Bm ; Guan H; Niedbala W; Paterson GK; McInnes IB; Liew FY J Immunol; 2001 Jul; 167(1):277-82. PubMed ID: 11418660 [TBL] [Abstract][Full Text] [Related]
58. [A system of assessing interleukin-2-dependent activation of B-lymphocytes]. Lozovoĭ VP; Kiselev SV; Kotenev VM Lab Delo; 1989; (7):60-2. PubMed ID: 2477606 [TBL] [Abstract][Full Text] [Related]
59. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Waldmann TA Nat Rev Immunol; 2006 Aug; 6(8):595-601. PubMed ID: 16868550 [TBL] [Abstract][Full Text] [Related]
60. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells. Leclercq G; Debacker V; de Smedt M; Plum J J Exp Med; 1996 Aug; 184(2):325-36. PubMed ID: 8760786 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]